UNSPSC 51123602: Dronedarone

This classification denotes an antiarrhythmic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) JQZ1L091Y2. European Medicines Agency schedules Dronedarone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06408MIG. Dronedarone generally arises in the molecular formula C31H44N2O5S.

The term DRONEDARONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 11, No. 11997, list 37.) Most nations, for tariff and trade purposes, schedule dronedarone under HS 29350090 and SITC 51580. As of Q4 2014, DRONEDARONE remains US FDA's Preferred Term for this commodity. Dronedarone bears US NLM identifiers UMLS ID C0766326 and NCI Concept Code C65485. SMILES: S(=O)(=O)(NC1CC2C(C(OC2CC1)CCCC)C(=O)C1CCC(OCCCN(CCCC)CCCC)CC1)C.

UNSPSC 51123602 Dronedarone, a Commodity code, covers pharmaceutical products procured by state and local emergency medical and public health agencies. The recent solicitation activity under this code reflects acquisition of emergency life support medications rather than dronedarone specifically—state and local buying patterns show procurement of advanced life support drugs including vasopressors, cardiac agents, and antiarrhythmics used by fire rescue and emergency medical services. The City of Tampa's April 2026 Advanced Life Support Medications bid (26P00188) exemplifies the scope: Tampa Fire Rescue sourced labetalol, epinephrine, adenosine, and diltiazem in unit quantities sufficient for operational stock, with firm pricing that includes freight, all costs bundled, and warranty coverage extending 365 days post-delivery. Issuing bodies under this code include municipal fire and emergency services departments procuring for operational use, characterized by sealed competitive bidding, firm fixed pricing, expedited delivery windows (ten calendar days in the Tampa case), minimum shelf-life requirements, and regulatory compliance documentation including Safety Data Sheets and accessibility reporting.

The Tampa solicitation represents activity in Florida; the source provides no additional geographic data to establish broader state or regional concentration. Tampa's bid, posted April 24, 2026 with a response due April 8, 2026 (a past deadline), carried an estimated contract value of $40,000 and included a 5 percent bid discount for Small Local Business Enterprise participation. The contract structure offers one-year initial terms with two one-year renewal options plus unilateral City extension authority for up to three additional 30-day periods. Award criteria center on lowest responsive, responsible bidder within a 120-day evaluation window, with the City reserving the right to award by division, aggregate, or cancel with ten days' notice for cause or thirty days' notice without cause.